Cargando…

Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis

Background: Great saphenous vein (GSV) grafts are used for coronary artery bypass surgeries, but the remaining stump of the GSV may be the nidus for superficial and deep vein thrombosis. This study aims to determine the risk of thrombosis in the GSV stump in patients who developed lower extremity sw...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Yasir, Cheema, Muhammad Arslan, Abdullah, Hafez Mohammad Ammar, Sattar, Yasar, Haq, Shujaul, Balaratna, Asoka, Cheema, Khadija, Ullah, Waqas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968707/
https://www.ncbi.nlm.nih.gov/pubmed/32002152
http://dx.doi.org/10.1080/20009666.2019.1655626
_version_ 1783489191524433920
author Khan, Yasir
Cheema, Muhammad Arslan
Abdullah, Hafez Mohammad Ammar
Sattar, Yasar
Haq, Shujaul
Balaratna, Asoka
Cheema, Khadija
Ullah, Waqas
author_facet Khan, Yasir
Cheema, Muhammad Arslan
Abdullah, Hafez Mohammad Ammar
Sattar, Yasar
Haq, Shujaul
Balaratna, Asoka
Cheema, Khadija
Ullah, Waqas
author_sort Khan, Yasir
collection PubMed
description Background: Great saphenous vein (GSV) grafts are used for coronary artery bypass surgeries, but the remaining stump of the GSV may be the nidus for superficial and deep vein thrombosis. This study aims to determine the risk of thrombosis in the GSV stump in patients who developed lower extremity swelling following coronary artery bypass graft (CABG). Methods: We conducted a single-center retrospective analysis at Abington Jefferson Hospital of 100 patients who underwent CABG with GSV. Patients were monitored via follow-up for seven days for the development of saphenous vein thrombosis without any prophylactic anticoagulation for venous thrombosis. Risk factors including age, diabetes, hypertension, smoking, familial thrombophilia’s, family history of thrombosis, malignancy, and confounding factor-like early mobilization that may potentially alter the results were recorded. Results: The mean age of included patients was 70 years, and 65% of participants were men, 35% were women. Fourteen percent of the patients developed pain, swelling and edema in a leg where the graft was taken. We included patients aged >50 years with coronary artery disease who underwent CABG with SVG and developed lower extremity symptoms concerning for thrombosis. These patients underwent duplex ultrasound for possible GSV stump thrombosis. Any patients with coronary artery disease but no CABG or no lower extremity edema were excluded from the study. We found no saphenous vein thrombosis in the stump of the GSV in patients with clinical symptoms of thrombosis in their lower extremities based on duplex imaging. Conclusion: Based on our findings, the postoperative risk of developing thrombosis at the GSV stump and its extension to the deep veins is low and does not warrant prophylactic anticoagulation for venous thromboembolism. However, we recommend that further prospective studies with larger samples for an extended duration are warranted for better assessment of the risk of venous thrombosis in the GSV stump with minimal confounding factors.
format Online
Article
Text
id pubmed-6968707
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-69687072020-01-30 Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis Khan, Yasir Cheema, Muhammad Arslan Abdullah, Hafez Mohammad Ammar Sattar, Yasar Haq, Shujaul Balaratna, Asoka Cheema, Khadija Ullah, Waqas J Community Hosp Intern Med Perspect Research Article Background: Great saphenous vein (GSV) grafts are used for coronary artery bypass surgeries, but the remaining stump of the GSV may be the nidus for superficial and deep vein thrombosis. This study aims to determine the risk of thrombosis in the GSV stump in patients who developed lower extremity swelling following coronary artery bypass graft (CABG). Methods: We conducted a single-center retrospective analysis at Abington Jefferson Hospital of 100 patients who underwent CABG with GSV. Patients were monitored via follow-up for seven days for the development of saphenous vein thrombosis without any prophylactic anticoagulation for venous thrombosis. Risk factors including age, diabetes, hypertension, smoking, familial thrombophilia’s, family history of thrombosis, malignancy, and confounding factor-like early mobilization that may potentially alter the results were recorded. Results: The mean age of included patients was 70 years, and 65% of participants were men, 35% were women. Fourteen percent of the patients developed pain, swelling and edema in a leg where the graft was taken. We included patients aged >50 years with coronary artery disease who underwent CABG with SVG and developed lower extremity symptoms concerning for thrombosis. These patients underwent duplex ultrasound for possible GSV stump thrombosis. Any patients with coronary artery disease but no CABG or no lower extremity edema were excluded from the study. We found no saphenous vein thrombosis in the stump of the GSV in patients with clinical symptoms of thrombosis in their lower extremities based on duplex imaging. Conclusion: Based on our findings, the postoperative risk of developing thrombosis at the GSV stump and its extension to the deep veins is low and does not warrant prophylactic anticoagulation for venous thromboembolism. However, we recommend that further prospective studies with larger samples for an extended duration are warranted for better assessment of the risk of venous thrombosis in the GSV stump with minimal confounding factors. Taylor & Francis 2019-12-14 /pmc/articles/PMC6968707/ /pubmed/32002152 http://dx.doi.org/10.1080/20009666.2019.1655626 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Khan, Yasir
Cheema, Muhammad Arslan
Abdullah, Hafez Mohammad Ammar
Sattar, Yasar
Haq, Shujaul
Balaratna, Asoka
Cheema, Khadija
Ullah, Waqas
Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
title Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
title_full Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
title_fullStr Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
title_full_unstemmed Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
title_short Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
title_sort great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968707/
https://www.ncbi.nlm.nih.gov/pubmed/32002152
http://dx.doi.org/10.1080/20009666.2019.1655626
work_keys_str_mv AT khanyasir greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT cheemamuhammadarslan greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT abdullahhafezmohammadammar greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT sattaryasar greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT haqshujaul greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT balaratnaasoka greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT cheemakhadija greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis
AT ullahwaqas greatsaphenousveinstumpariskfactorforsuperficialdeepvenousthrombosisandanindicationforprophylacticanticoagulationaretrospectiveanalysis